CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Farmácia Bioquímica from Faculdade de Ciências Farmacêuticas de Ribeirão Preto (1987), master's at Fármacos e Medicamentos from Faculdade de Ciências Farmacêuticas de Ribeirão Preto (1995) and doctorate at Parasitology from Universidade Estadual de Campinas (2000). Has experience in Parasitology, focusing on Parasitology, acting on the following subjects: trypanosoma cruzi, doença de chagas, chagas disease, camundongos and peixe. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chagas disease treatment remains partially ineffective, involving specific therapies directed to the parasite as well as adjuvant therapies for the clinical manifestations. In Brazil, benznidazole (N-benzyl-2-nitroimidazole-acetamide) is the only drug available for the aetiological treatment but can cause side effects to the patients. Studies show that Ghrelin has an important cardioprote…
Chagas disease is one of the most serious parasitic diseases in Latin America. Currently, between 6 and 7 million people are infected, and about 40 million are at risk of becoming infected. The problem is congenital Chagas infection in endemic and non-endemic areas, may cause miscarriage, prematurity, growth retardation intrauterine placentitis, Intrauterine and neonatal death. Interactio…
| 4 / 3 | Completed research grants |
| 1 / 1 | Completed scholarships in Brazil |
| 5 / 4 | All research grants and scholarships |
| Associated processes | |